5-Chloro-2′-deoxycytidine Induces a Distinctive High-Resolution Mutational Spectrum of Transition Mutations In Vivo

Marisa Chancharoen,Zhiyu Yang,Esha D. Dalvie,Nina Gubina,Mathuros Ruchirawat,Robert G. Croy,Bogdan I. Fedeles,John M. Essigmann

DOI: https://doi.org/10.1021/acs.chemrestox.3c00358

2024-02-23

Chemical Research in Toxicology

Abstract:The biomarker 5-chlorocytosine (5ClC) appears in the DNA of inflamed tissues. Replication of a site-specific 5ClC in a viral DNA genome results in C → T mutations, which is consistent with 5ClC acting as a thymine mimic in vivo. Direct damage of nucleic acids by immune-cell-derived hypochlorous acid is one mechanism by which 5ClC could appear in the genome. A second, nonmutually exclusive mechanism involves damage of cytosine nucleosides or nucleotides in the DNA precursor pool, with subsequent utilization of the 5ClC deoxynucleotide triphosphate as a precursor for DNA synthesis. The present work characterized the mutagenic properties of 5ClC in the nucleotide pool by exposing cells to the nucleoside 5-chloro-2'-deoxycytidine (5CldC). In both <i>Escherichia coli</i> and mouse embryonic fibroblasts (MEFs), 5CldC in the growth media was potently mutagenic, indicating that 5CldC enters cells and likely is erroneously incorporated into the genome from the nucleotide pool. High-resolution sequencing of DNA from MEFs derived from the <i>gpt</i>Δ C57BL/6J mouse allowed qualitative and quantitative characterization of 5CldC-induced mutations; CG → TA transitions in 5'-GC(Y)-3' contexts (Y = a pyrimidine) were dominant, while TA → CG transitions appeared at a much lower frequency. The high-resolution mutational spectrum of 5CldC revealed a notable similarity to the Catalogue of Somatic Mutations in Cancer mutational signatures SBS84 and SBS42, which appear in human lymphoid tumors and in occupationally induced cholangiocarcinomas, respectively. SBS84 is associated with the expression of activation-induced cytidine deaminase (AID), a cytosine deaminase associated with inflammation, as well as immunoglobulin gene diversification during antibody maturation. The similarity between the spectra of AID activation and 5CldC could be coincidental; however, the administration of 5CldC did induce some AID expression in MEFs, which have no inherent expression of its gene. In summary, this work shows that 5CldC induces a distinct pattern of mutations in cells. Moreover, that pattern resembles human mutational signatures induced by inflammatory processes, such as those triggered in certain malignancies.

chemistry, medicinal,toxicology, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the mutagenic properties of 5 - chloro - 2' - deoxycytosine (5CldC) in cells, especially how 5CldC leads to specific mutation patterns in the nucleotide pool. The researchers added 5CldC to the cell culture medium and observed its effects on Escherichia coli and mouse embryonic fibroblasts (MEFs), especially the high - resolution mutation spectra of genomic DNA in these cells. The main purpose of the study was to determine whether 5CldC could induce specific mutation types and explore the similarities between these mutation patterns and the known mutation signatures in human cancers, especially those related to inflammation - associated cancer mutation signatures.

### Research Background

Chronic inflammation is a known risk factor for the development of multiple cancers. During the inflammation process, hypochlorous acid (HOCl) produced by neutrophils can react with intracellular nucleic acid precursors to generate 5 - chlorocytosine (5ClC). As a known biomarker of chronic inflammation, 5ClC can cause mutations in DNA. In addition, 5ClC can also be inserted into the genome mediated by polymerase through reaction with deoxycytidine triphosphate (dCTP) or its precursors in the nucleotide pool, thereby causing mutations. Therefore, studying the mutagenic properties of 5CldC in cells is of great significance for understanding how inflammation promotes the occurrence and development of cancer.

### Research Methods

1. **Bacterial cell culture**: Escherichia coli (E. coli) was used for the experiment, and the mutagenic ability of 5CldC was evaluated by the rifampicin forward mutation test.
2. **Mammalian cell culture**: SV40 - immortalized mouse embryonic fibroblasts (MEFs) were used, and the inhibitory effect of 5CldC on cell growth was evaluated by the ATP luciferase cell viability test.
3. **gpt mutation test**: The mutation frequency was measured by 6 - thioguanine (6 - TG) - resistant colonies in the selective medium.
4. **Double - stranded consensus sequencing (DCS)**: High - resolution sequencing was performed on the genomic DNA of MEFs to identify specific mutation types and context - dependence.

### Main Findings

1. **Mutagenicity of 5CldC in E. coli**: 5CldC significantly increased the mutation frequency in E. coli, mainly manifested as C→T transition mutations.
2. **Mutagenicity of 5CldC in MEFs**: MEFs treated with 5CldC showed a significant increase in mutation frequency, with the main mutation type being CG→TA transitions, followed by TA→CG transitions.
3. **Specificity of mutation patterns**: The mutations induced by 5CldC mainly occurred in the 5′ - GC(Y) - 3′ context (Y is a pyrimidine), and the C→T mutation frequency on the coding strand was higher than that on the non - coding strand.
4. **Comparison with human cancer mutation signatures**: The mutation pattern induced by 5CldC was highly similar to the known mutation signatures SBS84 and SBS42 in human cancers, especially SBS84, which was related to the expression of activation - induced cytidine deaminase (AID).

### Conclusion

This study revealed the mutagenic properties of 5CldC in cells and found that the mutation pattern it induced was similar to the mutation signatures in some human cancers. These results are helpful for understanding how chronic inflammation promotes the development of cancer through specific chemicals such as 5CldC, and provide an important basis for further research.